Medical and Pharmaceutical Industry Technology and Development Center

Taidoc Technology Corporation

Pharmaceutical Industry Technology and Development Center

Center Laboratories, Inc.

Medical and Pharmaceutical Industry Technology and

Chih-Chiang Yang

Wen-Che Wang

Lai-Cheng Chin

Yi-Hsin Huang

Hui-Yu Chen

Tse-Ching Lin

Chao-Wang Chen

Meng-Ju Lee

Shu-Hsien Chang

Shih-Ku Lin

Pei-Ying Liao

Pei Hsuan Ho

Chiao-Ling Hsu

Yuan-Chih Le

Tai-Yin Ke

Tzu-Yu Chien

Meng-Kun Tsai

Ko-Chiang Chen

Chien-Chia Wu

The present invention is concerned with a modified release pharmaceutical composition comprising an effective amount of at least one antipsychotic agent so that the antipsychotic agent(s) are released in such a manner to better accord with physiological and chronotherapeutic requirements of patients.

Modified release pharmaceutical composition and method for the treatment of mental disorders

An oral composition includes an immediate-release pharmaceutical admixture and an extended-release pharmaceutical admixture. The immediate-release pharmaceutical admixture includes a first portion of an active ingredient and a first portion of a hydrophilic dispersant, in which the active ingredient is substantially insoluble in water. The extended-release pharmaceutical admixture includes a controlled-release material, a second portion of the active ingredient, and a second portion of the hydrophilic dispersant, wherein the second portion of the active ingredient and the second portion of the hydrophilic dispersant are mixed in the controlled-release material, wherein the active ingredient is present as a nanoparticle in the immediate-release pharmaceutical admixture and the extended-release pharmaceutical admixture.

Oral composition and methods for manufacturing the same and treatment

A pharmaceutical composition for colon targeting, a method for treating a colon-related disease using the same and a preparation method thereof are disclosed. The pharmaceutical composition of the present disclosure comprises: a core matrix comprising a cross-linked hydrogel and an active ingredient, wherein the active ingredient is dispersed in the cross-linked hydrogel, and a content of the active ingredient is 65 wt % to 95 wt % based on a total weight of the core matrix.

Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof

Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.

Oral pH independent dosage formulation for treating neurodegenerative disorders

The present invention related to an injector is provided. The injector includes a case body, a dose setting, a first engagement, a second engagement, an elasticity element, and a button. The dose setting is used to preset a dose. The first engagement is connected with the dose setting. The elasticity element is connected between the first engagement and the second engagement. When the elasticity element is in an extension state, the first engagement and the second engagement are separated. When the button is pushed, the elasticity element is entered into a compress state to combine the first engagement and the second engagement, and then push the dose setting.

Injector

An ear cap supplying device, an ear cap and an ear cap set are provided. The ear cap supplying device includes a movable containing device and an output device. The movable containing device is used for containing at least one ear cap. The output device is used for exporting the ear cap(s). When the movable containing device is moved to a predetermined position, the movable containing device activizes the output device to export the ear cap(s). Whereby, problem that the ear cap(s) is/are obstructed during exporting process can be improved.

Ear cap supplying device, ear cap and ear cap set

A method of preparing a taste-masking oral dosage form is provided. The method includes providing a first solution comprising a pharmaceutically active ingredient and a starch, providing a second solution comprising a hydrophilic polymer and a surfactant, blending the first and second solution to form a plurality of microparticles by a granulating process, wherein the microparticle is a co-crystal structure comprising the pharmaceutically active ingredient and the starch, and performing a compression-molding process to form the tablet.

Method of preparing a taste-masking oral dosage form

The present invention provides a method for making a fast dissolving tablet. The method includes the steps of (a) preparing a first solution containing a hydrophilic polymer and a starch; (b) preparing a second solution containing a pharmaceutically active ingredient and a surfactant; (c) blending the first and the second solution together to form a plurality of granule powders by granulation; (d) mixing the granule powders with excipients; and (e) applying a compression-molding process to form the fast dissolving tablet.

Fast dissolving tablet and method of preparing the same

Growing community of inventors

Taipei, Taiwan

Chih-Chiang Yang